Chimeric Therapeutics Limited Stock Price Prediction
| CHMMF Stock | 0 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Chimeric Therapeutics hype-based prediction, you can estimate the value of Chimeric Therapeutics Limited from the perspective of Chimeric Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Chimeric Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Chimeric because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Chimeric Therapeutics after-hype prediction price | USD 0.001 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chimeric |
Chimeric Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Chimeric Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chimeric Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Chimeric Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Chimeric Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Chimeric Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chimeric Therapeutics' historical news coverage. Chimeric Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Chimeric Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Chimeric Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Chimeric Therapeutics is based on 3 months time horizon.
Chimeric Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Chimeric Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chimeric Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chimeric Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Chimeric Therapeutics Hype Timeline
Chimeric Therapeutics is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Chimeric is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Chimeric Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 48.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. Chimeric Therapeutics had not issued any dividends in recent years. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Chimeric Therapeutics Basic Forecasting Models to cross-verify your projections.Chimeric Therapeutics Related Hype Analysis
Having access to credible news sources related to Chimeric Therapeutics' direct competition is more important than ever and may enhance your ability to predict Chimeric Therapeutics' future price movements. Getting to know how Chimeric Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chimeric Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QNNTF | Quantum Genomics Socit | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| THER | Therasense | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIANY | LianBio | 0.00 | 0 per month | 6.72 | 0.1 | 12.73 | (15.15) | 60.61 | |
| CUBT | Curative Biotechnology | 0.0005 | 3 per month | 10.95 | 0.04 | 18.18 | (21.35) | 76.47 | |
| BETRF | BetterLife Pharma | 0.00 | 0 per month | 0.00 | (0.02) | 20.77 | (17.02) | 49.65 | |
| PHRRF | Pharmather Holdings | 0.00 | 0 per month | 0.00 | (0.15) | 9.64 | (11.82) | 51.99 | |
| TWSI | Tristar Wellness | 0.00 | 0 per month | 7.74 | 0.08 | 20.83 | (15.38) | 103.48 | |
| NSHSF | Nanosphere Health Sciences | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 192.68 | |
| GLWLF | Glow Lifetech Corp | 0.00 | 0 per month | 1.66 | 0.06 | 3.93 | (2.78) | 25.72 | |
| TXTM | Protext Mobility | 0.00 | 0 per month | 5.51 | 0.04 | 16.13 | (9.76) | 32.26 |
Chimeric Therapeutics Additional Predictive Modules
Most predictive techniques to examine Chimeric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chimeric using various technical indicators. When you analyze Chimeric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Chimeric Therapeutics Predictive Indicators
The successful prediction of Chimeric Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chimeric Therapeutics Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chimeric Therapeutics based on analysis of Chimeric Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chimeric Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chimeric Therapeutics's related companies.
Story Coverage note for Chimeric Therapeutics
The number of cover stories for Chimeric Therapeutics depends on current market conditions and Chimeric Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chimeric Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chimeric Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Chimeric Pink Sheet analysis
When running Chimeric Therapeutics' price analysis, check to measure Chimeric Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimeric Therapeutics is operating at the current time. Most of Chimeric Therapeutics' value examination focuses on studying past and present price action to predict the probability of Chimeric Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimeric Therapeutics' price. Additionally, you may evaluate how the addition of Chimeric Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |